Literature DB >> 8541940

'Soundex' codes of surnames provide confidentiality and accuracy in a national HIV database.

J Y Mortimer1, J A Salathiel.   

Abstract

Clinicians and microbiologists will participate in voluntary national reporting of HIV infections and AIDS only if they have confidence in the scheme's confidentiality. At the same time, if the data are to be accurate, it must be possible to recognise reports that refer to the same individual. The use of surname 'soundex' code in combination with date of birth meets both requirements. We describe its use in the database of reported HIV infections held at the PHLS AIDS Centre. By the end of 1994 over 93% of the 20,407 reports on the database were soundex coded, and 70% of AIDS reports were linked to independent reports of HIV infection from microbiologists. In 1994, 22% of the reports of HIV infection were recognised as duplicating earlier reports of infection. Coding surnames using soundex is an acceptable and practical tool in surveillance of an infection for which confidentiality is a prime concern.

Entities:  

Mesh:

Year:  1995        PMID: 8541940

Source DB:  PubMed          Journal:  Commun Dis Rep CDR Rev        ISSN: 1350-9349


  23 in total

1.  Black Caribbean adults with HIV in England, Wales, and Northern Ireland: an emerging epidemic?

Authors:  S Dougan; L J C Payne; A E Brown; K A Fenton; L Logan; B G Evans; O N Gill
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

2.  Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection.

Authors:  L J Brant; M Hurrelle; M A Balogun; P Klapper; F Ahmad; E Boxall; A Hale; V Hollyoak; I B Ibrahim; W Irving; R Meigh; K J Mutton; B C Patel; W K Paver; S Pugh; C Taylor; A J Turner; M E Ramsay
Journal:  Epidemiol Infect       Date:  2006-07-13       Impact factor: 2.451

3.  Does the recent increase in HIV diagnoses among men who have sex with men in the UK reflect a rise in HIV incidence or increased uptake of HIV testing?

Authors:  Sarah Dougan; Jonathan Elford; Timothy R Chadborn; Alison E Brown; Kirsty Roy; Gary Murphy; O Noel Gill
Journal:  Sex Transm Infect       Date:  2006-11-07       Impact factor: 3.519

4.  Probabilistic master lists: integration of patient records from different databases when unique patient identifier is missing.

Authors:  Farrokh Alemi; Francisco Loaiza; Jee Vang
Journal:  Health Care Manag Sci       Date:  2007-02

5.  Epidemiology of HIV among black and minority ethnic men who have sex with men in England and Wales.

Authors:  S Dougan; J Elford; B Rice; A E Brown; K Sinka; B G Evans; O N Gill; K A Fenton
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

6.  Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999.

Authors:  T Djuretic; J Herbert; F Drobniewski; M Yates; E G Smith; J G Magee; R Williams; P Flanagan; B Watt; A Rayner; M Crowe; M V Chadwick; A M Middleton; J M Watson
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

7.  Monitoring the incidence of HIV infection in the United States.

Authors:  Lisa M Lee; Matthew T McKenna
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

8.  The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999 2003.

Authors:  Aliko B Ahmed; Ibrahim Abubakar; Valerie Delpech; Marc Lipman; Delia Boccia; Josh Forde; Delphine Antoine; John M Watson
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

9.  Recent trends in diagnoses of HIV and other sexually transmitted infections in England and Wales among men who have sex with men.

Authors:  N Macdonald; S Dougan; C A McGarrigle; K Baster; B D Rice; B G Evans; K A Fenton
Journal:  Sex Transm Infect       Date:  2004-12       Impact factor: 3.519

10.  Diagnoses of HIV-1 and HIV-2 in England, Wales, and Northern Ireland associated with west Africa.

Authors:  S Dougan; B Patel; J H Tosswill; K Sinka
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.